Erratum: Serum mucosa-associated epithelial chemokine in atopic dermatitis: A specific marker for severity (Indian Journal of Dermatology (2009) 54:3 (229-236) DOI: 10.4103/0019-5154.55630);Serum mucosa-associated epithelial chemokine in atopic dermatitis : AA specific marker for severity

Indian Journal of Dermatology

Volumn 54, Issue 3, 2009, Pages 229-236

  Ezzat, M H M ^a,b   Shaheen, K Y ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b NONE   (Egypt)

Author keywords

Atopy; CCL28; Mucosa associated epithelial chemokine

Indexed keywords

ANTIHISTAMINIC AGENT; CHEMOKINE; CORTICOSTEROID; IMMUNOGLOBULIN E; LACTATE DEHYDROGENASE; MUCOSA ASSOCIATED EPITHELIAL CHEMOKINE; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ARTICLE; ASTHMA; ATOPIC DERMATITIS; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; COURSE EVALUATION; CYTOKINE RELEASE; DISEASE EXACERBATION; DISEASE SEVERITY; DORMANCY; EOSINOPHIL COUNT; FEMALE; FOLLOW UP; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOGENESIS; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REMISSION; SEX DIFFERENCE;

EID: 70349434900     PISSN: 00195154     EISSN: 19983611     Source Type: Journal    
DOI: 10.4103/0019-5154.143618     Document Type: Erratum

References (32)

1. Olesen AB, Andersen G, Jeppesen DL, Benn CS, Juul S, Thestrup-Pedersen K. Thymus is enlarged in children with current atopic dermatitis: A cross-sectional study. Acta Derm Venereol 2005;85:240-243
2. Vestergaard C, Johansen C, Otkjaer K, Deleuran M, Iversen L. Tumor necrosis factor-alpha-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB. Cytokine 2005;29:49-55.
3. Hieshima K, Ohtani H, Shibano M, Izawa D, Nakayama T, Kawasaki Y, et al. CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity. J Immunol 2003;170:1452-1461
4. Wang W, Soto H, Oldham ER, Buchanan ME, Homey B, Catron D, et al. Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2). J Biol Chem 2000;275:22313-22323
5. Wilson E, Butcher EC. CCL28 controls immunoglobulin (Ig)A plasma cell accumulation in the lactating mammary gland and IgA antibody transfer to the neonate. J Exp Med 2004;200:805-809
6. Hieshima K, Kawasaki Y, Hanamoto H, Nakayama T, Nagakubo D, Kanamaru A, et al. CC chemokine ligands 25 and 28 play essential roles in intestinal extravasation of IgA antibody- secreting cells. J Immunol 2004;173:3668-3675
7. th ed. Philadelphia: WB Saunders Company; 2004. p. 774-778
8. Sowden JM, Berth-Jones J, Ross JS, Motley RJ, Marks R, Finlay AY, et al. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 1991;338:137-140
9. Kunz B, Oranje AP, Labreze L, Stalder JF, Ring J, Taieb A. Clinical validation and guidelines for the SCORAD index: Consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997;195:10-19
10. Pucci N, Novembre E, Cammarata MG, Bernardini R, Monaco MG, Calogero C, et al. Scoring atopic dermatitis in infants and young children: Distinctive features of the SCORAD index. Allergy 2005;60:113-116
11. Sprikkelman AB, Tupker RA, Burgerhof H, Schouten JP, Brand PL, Heymans HS, et al. Severity scoring of atopic dermatitis: A comparison of three scoring systems. Allergy 1997;52:944-949
12. thed. Philadelphia: WB Saunders; 2004. p. 760-773
13. National Heart, Lung, and Blood Institute (NHLBI). National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. In: NIH Publication No. 97-4051A. Bethesda, MD, US Department of Health and Human Services, National Institute of Health, 1997.
14. rd ed. New York: Churchill Livingston; 2000. p. 2520-2528
15. Kagami S, Kakinuma T, Saeki H, Tsunemi Y, Fujita H, Sasaki K, et al. Increased serum CCL28 levels in patients with atopic dermatitis, psoriasis vulgaris and bullous pemphigoid. J Invest Dermatol 2005;124:1088-1090
16. Homey B, Alenius H, Muller A, Soto H, Bowman EP, Yuan W, et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002;8:157-165
17. Morales J, Homey B, Vicari AP, Hudak S, Oldham E, Hedrick J, et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci USA 1999;96:14470-14475
18. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol Immunol 2002;38:881-885
19. Hijnen D, De Bruin-Weller M, Oosting B, Lebre C, De Jong E, Bruijnzeel-Koomen C, et al. Serum thymus and activationregulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 2004;113:334-340
20. Kakinuma T, Saeki H, Tsunemi Y, Fujita H, Asano N, Mitsui H, et al. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. J Allergy Clin Immunol 2003;111:592-597
21. + (thymocyte-like) T lymphocytes present in blood and skin from patients with atopic dermatitis suggest immune dysregulation. Br J Dermatol 2001;144:1140-1147
22. Giustizieri ML, Mascia F, Frezzolini A, De Pita O, Chinni LM, Giannetti A, et al. Keratinocytes from patients with atopic dermatitis and psoriasis vulgaris show a distinct chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol 2001;107:87l-7.
23. Reiss Y, Proudfoot AE, Power CA, Campbell JJ, Butcher EC. CC chemokine receptor (CCR) 4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 2001;194:1541-1547
24. John AE, Thomas MS, Berlin AA, Lukacs NW. Temporal production of CCL28 corresponds to eosinophil accumulation and airway hyperreactivity in allergic airway inflammation. Am J Pathol 2005;166:345-353
25. Humbles AA, Lu B, Friend DS, Okinaga S, Lora J, Al- Garawi A, et al. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyper responsiveness. Proc Natl Acad Sci USA 2002;99:1479-1484
26. Charman C, Chambers C, Williams H. Measuring atopic dermatitis severity in randomized controlled clinical trials: What exactly are we measuring? J Invest Dermatol 2003;120:932-941
27. Laske N, Niggemann B. Does the severity of atopic dermatitis correlate with serum IgE levels? Pediatr Allergy Immunol 2004;15:86-88
28. Rokaite R, Labanauskas L, Vaideliene L. Role of the skin patch test in diagnosing food allergy in children with atopic dermatitis. Medicina (Kaunas) 2004;40:1081-1087
29. Seidenari S, Guisti F, Bertoni L, Mantovani L. Combined skin prick and patch testing enhances identification of peanut allergic patients with atopic dermatitis. Allergy 2003;58:495.
30. Ma W, Bryce PJ, Humbles AA, Laouini D, Yalcindag A, Alenius H, et al. CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. J Clin Invest 2002;109:621-628
31. Mukai H, Noguchi T, Kamimura K, Nishioka K, Nishiyama S. Significance of elevated serum LDH (lactate dehydrogenase) activity in atopic dermatitis. J Dermatol 1990;17:477-481
32. Jacyk WK, Ungerer JP. Serum lactate dehydrogenase activity in exfoliative dermatitis. J Dermatol 1991;18:743.